Proactive Investors - Run By Investors For Investors

SEND platform the star first-half performer for Instem PLC

Phil Reason, chief executive of Instem Plc (LON:INS), caught up with Proactive to discuss their first-half 2018 trading update.

He says trading's been in line with expectations with the standout performer being their SEND platform where the value of contracts won so far this year has exceeded the total for all of 2017.

In all, Instem had 103 orders in the first six months from 50 different clients.

Meet Alliance Pharma plc, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full INS profile View Profile

Instem Plc Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use